Diagnostic Center | March 03, 2024
Biomind Labs announces positive results of Phase 2 clinical trial of BMND08 for depression & anxiety in Alzheimer’s disease
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg